CoChat

Prevention of Mantle Lymphoma Tumor Establishment by Routing Transferrin Receptor toward Lysosomal Compartments

Open access
Lepelletier, Yves, Camara-Clayette, Valérie, Jin, Hulin, Hermant, Aurélie, Coulon, Séverine, Dussiot, Michaël, Arcos-Fajardo, Michelle, Baude, Cédric, Canionni, Danielle, Delarue, Richard, Brousse, Nicole, Benaroch, Philippe, Benhamou, Marc, Ribrag, Vincent, Monteiro, Renato C., Moura, Ivan C., Hermine, Olivier · 2007 · Cancer Research
Cited by 37

The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.

Abstract

Mantle cell lymphoma (MCL) is one of the most frequent of the newly recognized non-Hodgkin's lymphomas. The major problem of MCL therapy is the occurrence of relapse and subsequent resistance to chemotherapy and immunotherapy in virtually all cases. Here, we show that one injection of anti-human transferrin receptor (TfR) monoclonal antibody A24 totally prevented xenografted MCL tumor establishment in nude mice. It also delayed and inhibited tumor progression of established tumors, prolonging mice survival. In vitro, A24 induced up to 85% reduction of MCL cell proliferation (IC50 = 3.75 nmol/L) independently of antibody aggregation, complement-dependent or antibody-dependent cell-mediated cytotoxicity. A24 induced MCL cell apoptosis through caspase-3 and caspase-9 activation, either alone or synergistically with chemotherapeutic agents. A24 induced TfR endocytosis via the clathrin adaptor protein-2 complex pathway followed by transport to lysosomal compartments. Therefore, A24-based therapies alone or in association with classic chemotherapies could provide a new alternative strategy against MCL, particularly in relapsing cases. [Cancer Res 2007;67(3):1145–54]

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1158/0008-5472.can-06-1962

Cites

2 of 2 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cited by

See all 37

Metadata

Authors
Lepelletier, Y., Camara-Clayette, V., Jin, H., Hermant, A., Coulon, S., Dussiot, M., Arcos-Fajardo, M., Baude, C., Canionni, D., Delarue, R., Brousse, N., Benaroch, P., Benhamou, M., Ribrag, V., Monteiro, R. C., Moura, I. C., & Hermine, O.
Venue
Cancer Research
Published
2007-02-01
Volume
67
Issue
3
Pages
1145-1154
ISSN
  • 0008-5472 (ISSN-L)
  • 1538-7445
OpenAlex
W2073055972
Cited by
37
References
2
FWCI
2.69
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Prevention of Mantle Lymphoma Tumor Establishment by Routing Transferrin Receptor toward Lysosomal Compartments. https://app.cochat.ai/papers/10.1158/0008-5472.can-06-1962
The paper
Lepelletier, Y., Camara-Clayette, V., Jin, H., Hermant, A., Coulon, S., Dussiot, M., Arcos-Fajardo, M., Baude, C., Canionni, D., Delarue, R., Brousse, N., Benaroch, P., Benhamou, M., Ribrag, V., Monteiro, R. C., Moura, I. C., & Hermine, O. (2007). Prevention of Mantle Lymphoma Tumor Establishment by Routing Transferrin Receptor toward Lysosomal Compartments. Cancer Research. https://doi.org/10.1158/0008-5472.can-06-1962

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.